This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Zacks.com featured highlights include StoneCo, PagSeguro Digital, KT, Arrow Electronics and CVS Health
by Zacks Equity Research
Zacks spotlights StoneCo, PagSeguro Digital, KT, Arrow Electronics, and CVS Health as attractive low price-to-book stocks with strong growth prospects.
Zacks.com featured highlights include Hasbro, Peloton Interactive, Carvana, CVS Health and Kinross Gold
by Zacks Equity Research
Zacks highlights Hasbro, Peloton Interactive, Carvana, CVS Health, and Kinross Gold as top-ranked stocks poised for potential earnings beats this season.
Will Rising Costs Hurt Elevance's Q3 Earnings Despite Higher Premiums?
by Zacks Equity Research
ELV's third-quarter earnings may face pressure as rising costs and weaker Medicaid memberships offset premium gains.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
5 Low Price-to-Book Stocks Worth Considering in October
by Kinjel Shah
STNE, CVS, KT, PAGS and ARW are five low price-to-book stocks that combine value appeal with solid growth potential.
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks
by Sanghamitra Saha
Top-ranked stocks Hasbro (HAS), Peloton Interactive (PTON), Carvana (CVNA), CVS Health (CVS) and Kinross Gold (KGC) are likely to beat on the bottom line in their upcoming releases.
CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock?
by Moumi Mondal
CVS' Aetna shines in 2026 Medicare Star Ratings, with more than 81% of members in four-star plans, fueling a 73.5% YTD stock surge and strong investor momentum.
CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $77.9, marking a +1.51% move from the previous day.
CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions
by Moumi Mondal
CVS company, Aetna, expands its Aetna Clinical Collaboration program to 10 hospitals, aiming to cut readmissions and ease hospital workloads.